The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients ; volume:11 ; number:2 ; day:6 ; month:3 ; year:2009 ; pages:1-11 ; date:4.2009
Arthritis Research & Therapy ; 11, Heft 2 (6.3.2009), 1-11, 4.2009
- Urheber
-
Dwivedi, Ravi C.
- Beteiligte Personen und Organisationen
-
Dhindsa, Navjot
Krokhin, Oleg V.
Cortens, John
Wilkins, John A.
El-Gabalawy, Hani S.
SpringerLink (Online service)
- DOI
-
10.1186/ar2637
- URN
-
urn:nbn:de:1111-2016050311871
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dwivedi, Ravi C.
- Dhindsa, Navjot
- Krokhin, Oleg V.
- Cortens, John
- Wilkins, John A.
- El-Gabalawy, Hani S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synovial fluid proteome in rheumatoid arthritis
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
P10.10 Effect of the Treatment of Rheumatoid Arthritis with Anti-Tnf-A Infliximab on Arterial Wall Stiffness Parameters
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
Synovial fluid proteome in rheumatoid arthritis
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
P10.10 Effect of the Treatment of Rheumatoid Arthritis with Anti-Tnf-A Infliximab on Arterial Wall Stiffness Parameters
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
Synovial fluid proteome in rheumatoid arthritis
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
P10.10 Effect of the Treatment of Rheumatoid Arthritis with Anti-Tnf-A Infliximab on Arterial Wall Stiffness Parameters
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients